Memorial Sloan Kettering Cancer Center
New York, New York
Dr. Jhaveri is an Associate Attending Physician and serves as Section Head for the Endocrine Therapy Research Program within the Breast Medicine Service and as Clinical Director for the Early Drug Development Service at MSKCC. She is an Associate Professor in the Department of Medicine (DOM) at Weill Cornell Medicine in NY. She earned her medical degree followed by a training in nuclear medicine from the University of Mumbai. She later completed her Internal Medicine residency from Icahn School of Medicine at Mount Sinai (Morningside/West) Program in NY and her Medical Oncology/ Hematology fellowship at MSKCC. From July 2012-May 2015, she served as an Assistant Professor in the DOM at New York University and as an Attending Physician at the Langone Medical Center and at Bellevue Hospital.
Dr. Jhaveri’s research interests focus on the development of improved therapies for patients with breast cancer, by conducting novel clinical trials integrated with translational biomarker work through acquired biospecimen or imaging analyses. She has led the development of PI3K/Akt inhibitors, FGFR inhibitors, ERBB2 inhibitors, oral SERD’s, Antibody-drug conjugates, amongst others.
Dr. Jhaveri is a recent recipient of the Patricia and James Cayne Chair for Junior Faculty at MSKCC. She serves as a member of the ASCO/TAPUR Molecular Tumor Board and is currently a member of the Developmental Therapeutics Track. She is Co-Chair for the Endocrine Resistance working group within the Translational Breast Cancer Research Consortium. Her work has been presented at annual scientific meetings and has been published widely in many reputable journals.
Session 14: CDK4/6 Inhibitors Results in Early and Metastatic Breast Cancer
Thursday, November 2, 2023
4:45 PM – 5:20 PM ET
Thursday, November 2, 2023
5:20 PM – 5:30 PM ET